Skip to main content

Animations

MJFF Publications

3271 - 3280 of 9156 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2021
  • 2021
  • 2021
  • 2021
  • 2019
  • 2021
  • 2019
  • 2023
  • Summary Details
    OPEN
    Title: Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-191576
    Citation Count: 130
  • Summary Details
    OPEN
    Title: Deubiquitinase USP29 Governs MYBBP1A in the Brains of Parkinson’s Disease Patients
    Journal Name: Journal of Clinical Medicine
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/jcm9010052
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.12254
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathies
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02323-1
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Striatal ΔFosB gene suppression inhibits the development of abnormal involuntary movements induced by L-Dopa in rats
    Journal Name: Gene Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41434-021-00249-7
    Citation Count: 16
  • Summary Details
    OPEN
    Title: The triple aim of clinical research
    Journal Name: Clinical Trials
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/17407745211001522
    Citation Count: 10
  • Early‐onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation
    2019
    Summary Details
    RESTRICTED
    Title: Early‐onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27710
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00259-021-05302-6
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Home‐Based Monitoring of Falls Using Wearable Sensors in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27830
    Citation Count: 118
  • Summary Details
    OPEN
    Title: Preface to the 4th MDS Video Challenge Case Supplement for Movement Disorders Clinical Practice
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13832
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.